Flash poster presentation slide of IUPHAR Guide to PHARMACOLOGY. As presented by Dr. Simon Harding at BPS Pharmacology 2016 @BritPharmSoc @GuidetoPHARM
The GtoImmuPdb Portal aims to provide a unique access point for immunological data within the Guide to Pharmacology (GtoPdb) database. It will contain expert-curated immunological information on protein targets and ligands tagged as immunologically relevant. The portal will assist in identifying potential drug targets and experimental molecules for testing, and will link targets and ligands to immunological processes, cell types, and related diseases. A beta version of GtoImmuPdb is scheduled for release in Spring 2017.
A Wellcome Trust-funded project to extend the Guide to PHARMACOLOGY (www.guidetopharmacology.org) to include data on key immunological data types and associate these to drugs and drug targets. Presented at the ELIXIR-UK All-Hand Meeting, Edinburgh, Nov 2017.
IUPHAR Guide to IMMUNOPHARMACOLOGY poster. Presented at the BSI Congress 2017, Brighton, UK (6th December 2017) and at Pharmacology 2017, London, UK (13th December 2017.
1) Researchers have created a new online resource called the IUPHAR/MMV Guide to Malaria Pharmacology (GtoMPdb) to curate information on antimalarial compounds and their molecular targets in Plasmodium.
2) The database currently contains 25 Plasmodium molecular targets and 57 antimalarial ligands that were manually curated from scientific literature.
3) A new customized online portal provides open access to the antimalarial data and allows browsing by parasite lifecycle stage, target species, and other features to help malaria research.
Find out about collaboration and partnership opportunities with the Wellcome Sanger Institute that aims to create exceptional healthcare opportunities for everyone from extraordinary science.
How can Whole Genome Sequencing information be used to address data requireme...OECD Environment
This document discusses the potential use of whole genome sequencing data to address regulatory requirements for approval of microorganisms as active ingredients in plant protection products in the EU. It analyzes how genome sequencing could be used for species assignment, relationship to pathogens, distinction between Bacillus strains, production of metabolites, antibiotic resistance, genetic stability, risk assessment, and unequivocal identification of strains. While noting some potential benefits, it also describes limitations and problems with relying solely on genome sequencing data. It concludes that genome sequencing can be useful to exclude some issues but should not be a standard requirement, and that only reports on analyses—not the genome sequences themselves—should be included in dossiers.
The transient protein expression market was valued at US$ 660.00 million in 2019 and is projected to reach US$ 983.10 million by 2027; it is expected to grow at a CAGR of 5.3% from 2020 to 2027.
How bioinformatic and sequencing data might inform the regulatory process - O...OECD Environment
24 June 2019: This OECD seminar presented and discussed the potential use of genome sequence, bioinformatic tools and databases in a regulatory decision process for microbial pesticides.
The GtoImmuPdb Portal aims to provide a unique access point for immunological data within the Guide to Pharmacology (GtoPdb) database. It will contain expert-curated immunological information on protein targets and ligands tagged as immunologically relevant. The portal will assist in identifying potential drug targets and experimental molecules for testing, and will link targets and ligands to immunological processes, cell types, and related diseases. A beta version of GtoImmuPdb is scheduled for release in Spring 2017.
A Wellcome Trust-funded project to extend the Guide to PHARMACOLOGY (www.guidetopharmacology.org) to include data on key immunological data types and associate these to drugs and drug targets. Presented at the ELIXIR-UK All-Hand Meeting, Edinburgh, Nov 2017.
IUPHAR Guide to IMMUNOPHARMACOLOGY poster. Presented at the BSI Congress 2017, Brighton, UK (6th December 2017) and at Pharmacology 2017, London, UK (13th December 2017.
1) Researchers have created a new online resource called the IUPHAR/MMV Guide to Malaria Pharmacology (GtoMPdb) to curate information on antimalarial compounds and their molecular targets in Plasmodium.
2) The database currently contains 25 Plasmodium molecular targets and 57 antimalarial ligands that were manually curated from scientific literature.
3) A new customized online portal provides open access to the antimalarial data and allows browsing by parasite lifecycle stage, target species, and other features to help malaria research.
Find out about collaboration and partnership opportunities with the Wellcome Sanger Institute that aims to create exceptional healthcare opportunities for everyone from extraordinary science.
How can Whole Genome Sequencing information be used to address data requireme...OECD Environment
This document discusses the potential use of whole genome sequencing data to address regulatory requirements for approval of microorganisms as active ingredients in plant protection products in the EU. It analyzes how genome sequencing could be used for species assignment, relationship to pathogens, distinction between Bacillus strains, production of metabolites, antibiotic resistance, genetic stability, risk assessment, and unequivocal identification of strains. While noting some potential benefits, it also describes limitations and problems with relying solely on genome sequencing data. It concludes that genome sequencing can be useful to exclude some issues but should not be a standard requirement, and that only reports on analyses—not the genome sequences themselves—should be included in dossiers.
The transient protein expression market was valued at US$ 660.00 million in 2019 and is projected to reach US$ 983.10 million by 2027; it is expected to grow at a CAGR of 5.3% from 2020 to 2027.
How bioinformatic and sequencing data might inform the regulatory process - O...OECD Environment
24 June 2019: This OECD seminar presented and discussed the potential use of genome sequence, bioinformatic tools and databases in a regulatory decision process for microbial pesticides.
Project Unity: The Way of the Future for Plant BreedingPhenome Networks
Project Unity is a platform that will host all phenotype-to-genotype public-domain data in a common and unified platform, offered as a free service for academia. Each researcher will be able to load their data and connect it to existing global knowledge, by linking traits to ontology, markers to genetic/physical maps and germplasms to pedigree and their sources. Initially, each dataset is stored privately, and can only be accessed by the researcher comparing his results to public ones. Data is made public once the researcher decides to do so typically after the publication of the corresponding scientific paper.
Activities in development of bioinformatics pipelines for characterisation of...OECD Environment
24 June 2019: This OECD seminar presented and discussed the potential use of genome sequence, bioinformatic tools and databases in a regulatory decision process for microbial pesticides.
Bioinformatics: Building the cornerstones of Sequence Homology and its use fo...OECD Environment
24 June 2019: This OECD seminar presented and discussed the potential use of genome sequence, bioinformatic tools and databases in a regulatory decision process for microbial pesticides.
Introduction - OECD Seminar on Bioinformatics and Regulation of Microbial Pes...OECD Environment
24 June 2019: This OECD seminar presented and discussed the potential use of genome sequence, bioinformatic tools and databases in a regulatory decision process for microbial pesticides.
Traverse Biosciences has been granted a US patent covering its proprietary library of chemically-modified curcumin compounds, including its lead drug candidate TRB-N0224. The patent was exclusively licensed from the Research Foundation for the State University of New York. TRB-N0224 is being developed as a prescription treatment for canine periodontal disease and is also being evaluated for other animal and human conditions. The issuance of the patent provides intellectual property protection for Traverse Biosciences' novel drug candidates.
Potential value of bioinformatic analysis in regulatory process - OECD Bioinf...OECD Environment
24 June 2019: This OECD seminar presented and discussed the potential use of genome sequence, bioinformatic tools and databases in a regulatory decision process for microbial pesticides.
Finland conducts comprehensive surveillance of antimicrobial resistance (AMR) as required by law. The Finnish Institute for Health and Welfare (THL) is responsible for AMR surveillance at the national level. THL manages the FinRes database, which collects AMR data on 19 bacteria from 287,000 clinical isolates and 2 million antimicrobial susceptibility tests annually from laboratories across Finland. Data is also contributed to international surveillance networks such as EARS-Net, GLASS, and studies conducted by EFSA.
Dr. Simon D. Harding of the University of Edinburgh created a knowledge-base that connects immunology and pharmacology. The knowledge-base links immunological targets and ligands to cell types and diseases. It is part of the IUPHAR/BPS Guide to Pharmacology, an open database of drug targets and ligands including approved drugs. A new search tool allows searching of pharmacological information. Dr. Harding also aims to curate data on antimalarial compounds and their molecular targets in Plasmodium through the IUPHAR/MMV Guide to Malaria Pharmacology.
The document summarizes the results of a 2015 survey on whole genome sequencing (WGS) capacity in European Union and European Economic Area Member States. Nineteen countries reported having national reference laboratories with access to next generation sequencing technologies like Illumina, and over half were applying WGS to surveillance and outbreak investigations of pathogens. While use of WGS is expanding rapidly, future annual surveys are needed to continued monitoring increasing capacity.
Your manuscript "RBD targeted COVID vaccine and full length spike-protein vaccine (mutation and glycosylation role) relationship with procoagulant effect" has been accepted for publication in the Journal of Child, Adult Vaccines and Immunology pending revision. The letter from P U B L I C A T I O N S Corporation informs Dr. Luisetto Mauro that his article is currently under peer review and will be published after addressing feedback from reviewers.
The Global Micorbial Identifier (GMI) initiative - and its working groupsExternalEvents
http://www.fao.org/about/meetings/wgs-on-food-safety-management/en/
The GMI initiative - and its working groups. Presentation from the Technical Meeting on the impact of Whole Genome Sequencing (WGS) on food safety management -23-25 May 2016, Rome, Italy.
Bioinformatics and sequencing tools used in research and development - OECD B...OECD Environment
24 June 2019: This OECD seminar presented and discussed the potential use of genome sequence, bioinformatic tools and databases in a regulatory decision process for microbial pesticides.
Presentation from the ECDC expert consultation on Whole Genome Sequencing organised by the European Centre of Disease Prevention and Control - Stockholm, 19 November 2015
The study tested treatments of the pathogenic bacteria Pseudomonas aeruginosa with the bacteriophage LUZ7 alone, the antibiotic streptomycin alone, and a combination of the two. It found that a combined treatment was most effective at reducing bacterial density and inhibiting the development of antibiotic resistance when the antibiotic was added 12 hours after phage treatment, as this provided a window of opportunity for the phage to have the strongest impact before the antibiotic was introduced. Delaying antibiotic addition in this way had the strongest negative effect on the bacterial population and led to the lowest levels of resistance.
Presentation from the 3rd Joint Meeting of the Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI) Networks, organised by the European Centre of Disease Prevention and Control - Stockholm, 11-13 February 2015
OS20 - Molecular surveillance of Foot and Mouth Disease virus through slaught...EuFMD
This study evaluated using sampling of asymptomatic livestock at slaughterhouses in Vietnam for molecular surveillance of foot-and-mouth disease virus (FMDV). Samples collected from cattle and buffalo at two slaughterhouses showed viral diversity reflecting strains circulating in the source population. Phylogenetic analysis found that for some FMDV serotype O clades, slaughterhouse sequences pre-dated later outbreak sequences by 4-6 months, suggesting slaughterhouse sampling could provide early detection of emerging strains. Additionally, some farm sequences clustered with older outbreak sequences, indicating subclinical circulation may occur up to 18 months after observed outbreaks. The study concludes routine slaughterhouse sampling provides a cost-effective means for molecular surveillance to identify circulating and emerging FMDV strains in
An introduction to PATRIC and its use in phage annotationRamy K. Aziz
The document summarizes the Bacterial Bioinformatics Resource Center (BRC), which merges several bioinformatics resources to support infectious disease research. The BRC contains over 130,000 microbial genomes with uniform annotations across genes, proteins, pathways, and more. It also includes curated data on antimicrobial resistance for over 15,000 genomes. The BRC enables users to analyze genomes, perform comparative analyses, and has deployed machine learning to predict antimicrobial resistance phenotypes from genomic data.
Whole Genome Sequencing (WGS) for surveillance of foodborne infections in Den...ExternalEvents
http://www.fao.org/about/meetings/wgs-on-food-safety-management/en/
Applications of WGS for surveillance of foodborne infections in Denmark; benefits and potential drawbacks on performance and cost. Presentation from the Technical Meeting on the impact of Whole Genome Sequencing (WGS) on food safety management -23-25 May 2016, Rome, Italy.
Presentation from the ECDC expert consultation on Whole Genome Sequencing organised by the European Centre of Disease Prevention and Control - Stockholm, 19 November 2015
Real-Time Genome Sequencing of Resistant Bacteria Provides Precision Infectio...ExternalEvents
http://www.fao.org/about/meetings/wgs-on-food-safety-management/en/
Real-Time Genome Sequencing of Resistant Bacteria Provides Precision Infection Control in an Institutional Setting. Presentation from the Technical Meeting on the impact of Whole Genome Sequencing (WGS) on food safety management and GMI-9, 23-25 May 2016, Rome, Italy.
(First slide is recording of webinar). IUPHAR Web Resources, Simplifying Complexity for Medicine and Education. WDS Webinar#11 held on 28th February 2017.
IUPHAR (International Union of Basic and Clinical Pharmacology) has developed and is developing a series of web-based services for the Pharmacological Sciences, for education, and for drug discovery. These services enable the simplification and dissemination of highly complex datasets, via expert committees linked to ontologically-correct databases (e.g., the drug and receptor sites expressed by the human genome). This has also allowed IUPHAR—in connection with the main national pharmacological societies, particularly the British Pharmacological Society—to raise funds for curators and meetings. This simple model is open-ended and is being expanded to, for example, immunological targets and experimental protocols, and to educational projects.
Speakers: Michael Spedding, Adam Pawson, Steve Alexander, Joanna Sharman, Simon Harding, Jamie Davies, John Szarek and Lynn LeCount
This document discusses chronic inflammation and how certain diets can either induce or reduce inflammation. It begins by explaining how the immune system requires balance and how imbalances from nutrients consumed can lead to chronic inflammation over time. Chronic inflammation is linked to diseases like diabetes and vascular diseases. Certain foods and plant nutrients have been shown to reverse or slow inflammation and help treat chronic inflammatory diseases. The document then discusses how obesity and damaged adipose tissue can induce chronic inflammation through increased pro-inflammatory cytokines. Finally, it summarizes that diets high in antioxidants and fatty acids may help reduce inflammation and treat inflammatory conditions, though more research is still needed.
Project Unity: The Way of the Future for Plant BreedingPhenome Networks
Project Unity is a platform that will host all phenotype-to-genotype public-domain data in a common and unified platform, offered as a free service for academia. Each researcher will be able to load their data and connect it to existing global knowledge, by linking traits to ontology, markers to genetic/physical maps and germplasms to pedigree and their sources. Initially, each dataset is stored privately, and can only be accessed by the researcher comparing his results to public ones. Data is made public once the researcher decides to do so typically after the publication of the corresponding scientific paper.
Activities in development of bioinformatics pipelines for characterisation of...OECD Environment
24 June 2019: This OECD seminar presented and discussed the potential use of genome sequence, bioinformatic tools and databases in a regulatory decision process for microbial pesticides.
Bioinformatics: Building the cornerstones of Sequence Homology and its use fo...OECD Environment
24 June 2019: This OECD seminar presented and discussed the potential use of genome sequence, bioinformatic tools and databases in a regulatory decision process for microbial pesticides.
Introduction - OECD Seminar on Bioinformatics and Regulation of Microbial Pes...OECD Environment
24 June 2019: This OECD seminar presented and discussed the potential use of genome sequence, bioinformatic tools and databases in a regulatory decision process for microbial pesticides.
Traverse Biosciences has been granted a US patent covering its proprietary library of chemically-modified curcumin compounds, including its lead drug candidate TRB-N0224. The patent was exclusively licensed from the Research Foundation for the State University of New York. TRB-N0224 is being developed as a prescription treatment for canine periodontal disease and is also being evaluated for other animal and human conditions. The issuance of the patent provides intellectual property protection for Traverse Biosciences' novel drug candidates.
Potential value of bioinformatic analysis in regulatory process - OECD Bioinf...OECD Environment
24 June 2019: This OECD seminar presented and discussed the potential use of genome sequence, bioinformatic tools and databases in a regulatory decision process for microbial pesticides.
Finland conducts comprehensive surveillance of antimicrobial resistance (AMR) as required by law. The Finnish Institute for Health and Welfare (THL) is responsible for AMR surveillance at the national level. THL manages the FinRes database, which collects AMR data on 19 bacteria from 287,000 clinical isolates and 2 million antimicrobial susceptibility tests annually from laboratories across Finland. Data is also contributed to international surveillance networks such as EARS-Net, GLASS, and studies conducted by EFSA.
Dr. Simon D. Harding of the University of Edinburgh created a knowledge-base that connects immunology and pharmacology. The knowledge-base links immunological targets and ligands to cell types and diseases. It is part of the IUPHAR/BPS Guide to Pharmacology, an open database of drug targets and ligands including approved drugs. A new search tool allows searching of pharmacological information. Dr. Harding also aims to curate data on antimalarial compounds and their molecular targets in Plasmodium through the IUPHAR/MMV Guide to Malaria Pharmacology.
The document summarizes the results of a 2015 survey on whole genome sequencing (WGS) capacity in European Union and European Economic Area Member States. Nineteen countries reported having national reference laboratories with access to next generation sequencing technologies like Illumina, and over half were applying WGS to surveillance and outbreak investigations of pathogens. While use of WGS is expanding rapidly, future annual surveys are needed to continued monitoring increasing capacity.
Your manuscript "RBD targeted COVID vaccine and full length spike-protein vaccine (mutation and glycosylation role) relationship with procoagulant effect" has been accepted for publication in the Journal of Child, Adult Vaccines and Immunology pending revision. The letter from P U B L I C A T I O N S Corporation informs Dr. Luisetto Mauro that his article is currently under peer review and will be published after addressing feedback from reviewers.
The Global Micorbial Identifier (GMI) initiative - and its working groupsExternalEvents
http://www.fao.org/about/meetings/wgs-on-food-safety-management/en/
The GMI initiative - and its working groups. Presentation from the Technical Meeting on the impact of Whole Genome Sequencing (WGS) on food safety management -23-25 May 2016, Rome, Italy.
Bioinformatics and sequencing tools used in research and development - OECD B...OECD Environment
24 June 2019: This OECD seminar presented and discussed the potential use of genome sequence, bioinformatic tools and databases in a regulatory decision process for microbial pesticides.
Presentation from the ECDC expert consultation on Whole Genome Sequencing organised by the European Centre of Disease Prevention and Control - Stockholm, 19 November 2015
The study tested treatments of the pathogenic bacteria Pseudomonas aeruginosa with the bacteriophage LUZ7 alone, the antibiotic streptomycin alone, and a combination of the two. It found that a combined treatment was most effective at reducing bacterial density and inhibiting the development of antibiotic resistance when the antibiotic was added 12 hours after phage treatment, as this provided a window of opportunity for the phage to have the strongest impact before the antibiotic was introduced. Delaying antibiotic addition in this way had the strongest negative effect on the bacterial population and led to the lowest levels of resistance.
Presentation from the 3rd Joint Meeting of the Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI) Networks, organised by the European Centre of Disease Prevention and Control - Stockholm, 11-13 February 2015
OS20 - Molecular surveillance of Foot and Mouth Disease virus through slaught...EuFMD
This study evaluated using sampling of asymptomatic livestock at slaughterhouses in Vietnam for molecular surveillance of foot-and-mouth disease virus (FMDV). Samples collected from cattle and buffalo at two slaughterhouses showed viral diversity reflecting strains circulating in the source population. Phylogenetic analysis found that for some FMDV serotype O clades, slaughterhouse sequences pre-dated later outbreak sequences by 4-6 months, suggesting slaughterhouse sampling could provide early detection of emerging strains. Additionally, some farm sequences clustered with older outbreak sequences, indicating subclinical circulation may occur up to 18 months after observed outbreaks. The study concludes routine slaughterhouse sampling provides a cost-effective means for molecular surveillance to identify circulating and emerging FMDV strains in
An introduction to PATRIC and its use in phage annotationRamy K. Aziz
The document summarizes the Bacterial Bioinformatics Resource Center (BRC), which merges several bioinformatics resources to support infectious disease research. The BRC contains over 130,000 microbial genomes with uniform annotations across genes, proteins, pathways, and more. It also includes curated data on antimicrobial resistance for over 15,000 genomes. The BRC enables users to analyze genomes, perform comparative analyses, and has deployed machine learning to predict antimicrobial resistance phenotypes from genomic data.
Whole Genome Sequencing (WGS) for surveillance of foodborne infections in Den...ExternalEvents
http://www.fao.org/about/meetings/wgs-on-food-safety-management/en/
Applications of WGS for surveillance of foodborne infections in Denmark; benefits and potential drawbacks on performance and cost. Presentation from the Technical Meeting on the impact of Whole Genome Sequencing (WGS) on food safety management -23-25 May 2016, Rome, Italy.
Presentation from the ECDC expert consultation on Whole Genome Sequencing organised by the European Centre of Disease Prevention and Control - Stockholm, 19 November 2015
Real-Time Genome Sequencing of Resistant Bacteria Provides Precision Infectio...ExternalEvents
http://www.fao.org/about/meetings/wgs-on-food-safety-management/en/
Real-Time Genome Sequencing of Resistant Bacteria Provides Precision Infection Control in an Institutional Setting. Presentation from the Technical Meeting on the impact of Whole Genome Sequencing (WGS) on food safety management and GMI-9, 23-25 May 2016, Rome, Italy.
(First slide is recording of webinar). IUPHAR Web Resources, Simplifying Complexity for Medicine and Education. WDS Webinar#11 held on 28th February 2017.
IUPHAR (International Union of Basic and Clinical Pharmacology) has developed and is developing a series of web-based services for the Pharmacological Sciences, for education, and for drug discovery. These services enable the simplification and dissemination of highly complex datasets, via expert committees linked to ontologically-correct databases (e.g., the drug and receptor sites expressed by the human genome). This has also allowed IUPHAR—in connection with the main national pharmacological societies, particularly the British Pharmacological Society—to raise funds for curators and meetings. This simple model is open-ended and is being expanded to, for example, immunological targets and experimental protocols, and to educational projects.
Speakers: Michael Spedding, Adam Pawson, Steve Alexander, Joanna Sharman, Simon Harding, Jamie Davies, John Szarek and Lynn LeCount
This document discusses chronic inflammation and how certain diets can either induce or reduce inflammation. It begins by explaining how the immune system requires balance and how imbalances from nutrients consumed can lead to chronic inflammation over time. Chronic inflammation is linked to diseases like diabetes and vascular diseases. Certain foods and plant nutrients have been shown to reverse or slow inflammation and help treat chronic inflammatory diseases. The document then discusses how obesity and damaged adipose tissue can induce chronic inflammation through increased pro-inflammatory cytokines. Finally, it summarizes that diets high in antioxidants and fatty acids may help reduce inflammation and treat inflammatory conditions, though more research is still needed.
Systems Pharmacology as a tool for future therapy development: a feasibility ...Guide to PHARMACOLOGY
This study explores using a systems pharmacology approach to analyze the mevalonate branch of the cholesterol biosynthesis pathway. Kinetic parameters and inhibitors of the pathway enzymes were identified from literature and databases. An ordinary differential equation model of the pathway was built and used to predict the optimal drug combination that would suppress production of the cholesterol precursor squalene while maintaining production of geranylgeranyl-PP. The predicted multi-drug approach required a lower total dose than treatment with the statin drug rosuvastatin alone. However, the study found that incomplete and ambiguous pathway data as well as errors in databases currently limit full potential of systems pharmacology approaches.
This talk will be presented by Chris Southan, Database Curator and Chairperson of the NC-IUPHAR Drugs and Targets Annotation Subcommittee at the 17th World Congress of Basic and Clinical Pharmacology (WCP2014) taking place in Cape Town this month. The abstract for the talk can be read below:
Discerning the molecular mechanisms of action (mmoa) for drugs treating human diseases is crucially important. This talk will provide an overview of target numbers in IUPHAR/BPS Guide to PHARMACOLOGY, compare these to other sources and consider the wider implications for drug discovery. We have developed stringent mapping criteria for primary targets (i.e. identifying those direct protein interactions mechanistically causative for therapeutic efficacy). This includes inter-source corroboration by intersecting multiple drug sources inside PubChem to produce consensus structure sets. The analogous approach is used to intersect published target lists and database subsets at the UniProtKB/Swiss-Prot identity level. Our cumulative curation results reveal that structure representation differences, data provenance and variability of assay results, are major issues for experimental pharmacology and global database quality. While our activity mappings encompass some polypharmacology (e.g. dual inhibitors and kinase panel screens) our strategic choice is to annotate minimal rather than maximal target sets. The consequent increased precision gives our database high utility for data mining, linking and cross-referencing. Our small-molecule figures are currently converging to ~200 human protein primary targets for ~1000 consensus chemical structures of approved drugs. Target lists from other sources are typically larger and show a degree of discordance. Comparative analysis of these lists by their UniProt ID content and Gene Ontology distributions suggests differences in curatorial selection are the main cause of divergence. The global target landscape thus shows paradoxical trends. On the one hand, cumulative drug research output and recent expansions (e.g. epigenetic targets and orphan diseases) have pushed bioactive compounds from papers or patents to above 2 million and chemically modulatable human proteins above 1500 (PMID:24204758). On the other hand, reports of Phase II clinical efficacy failure, with implicit target de-validation, are frequent. In addition, our assessment of drug approval data from 2009 to 2013 indicates new targets (i.e. first-in-class mmoas) are so low as to threaten the sustainability of the pharmaceutical industry. Causes and consequences of these paradoxes, along with utilities for minimal and maximal druggable genomes, will be discussed.
Slicing and dicing curated protein targets: Analysing the drugged, druggable ...Guide to PHARMACOLOGY
Presented by team member Chris Southan in April 2015 at the BPS Focused meeting in Edinburgh: Exploiting the new pharmacology and application to drug discovery.
Navigating between publications and databases for drug discovery: IUPHAR/BPS ...Guide to PHARMACOLOGY
Presented by team member Joanna Sharman in April 2015 at the BPS Focused Meeting: Exploiting the new pharmacology and application to drug discovery in Edinburgh.
The document summarizes the history and development of the IUPHAR-DB database and the IUPHAR/BPS Guide to Pharmacology. It discusses how IUPHAR-DB was originally developed in 2000 to provide in-depth information on drug receptors and channels. In 2011, IUPHAR collaborated with the British Pharmacological Society to create a single online resource combining IUPHAR-DB and the 5th Edition of GRAC. This became the IUPHAR/BPS Guide to Pharmacology, which presents pharmacological information on drug targets and ligands in an accessible format. The Guide contains detailed data on many target families including kinases, proteases, epigenetic targets, and those implicated in Alzheimer's disease.
Prof Anthony Harmar, JR Vane Medal Lecture 2014: A tribute to Anthony Harmar ...Guide to PHARMACOLOGY
This document discusses Tony J. Harmar and his contributions to pharmacology. It notes that he received the Nobel Prize in 1982, was knighted in 1984, published over 700 papers and 20 books, and developed the Vane biocascade assay technique. It discusses his work on mechanisms of aspirin and prostaglandins. It also summarizes his role as Director of R&D at the Wellcome Foundation and founding the William Harvey Research Institute. The document highlights Harmar's role as chairman of the database committee for the International Union of Basic and Clinical Pharmacology (IUPHAR) and British Pharmacological Society (BPS) Guide to Pharmacology database. It discusses achievements and goals of the committee to continue
Each month, join us as we highlight and discuss hot topics ranging from the future of higher education to wearable technology, best productivity hacks and secrets to hiring top talent. Upload your SlideShares, and share your expertise with the world!
Not sure what to share on SlideShare?
SlideShares that inform, inspire and educate attract the most views. Beyond that, ideas for what you can upload are limitless. We’ve selected a few popular examples to get your creative juices flowing.
How to Make Awesome SlideShares: Tips & TricksSlideShare
Turbocharge your online presence with SlideShare. We provide the best tips and tricks for succeeding on SlideShare. Get ideas for what to upload, tips for designing your deck and more.
SlideShare is a global platform for sharing presentations, infographics, videos and documents. It has over 18 million pieces of professional content uploaded by experts like Eric Schmidt and Guy Kawasaki. The document provides tips for setting up an account on SlideShare, uploading content, optimizing it for searchability, and sharing it on social media to build an audience and reputation as a subject matter expert.
The IUPHAR/BPS Guide to PHARMACOLOGY (GtoPdb) is an expert-driven, open database of pharmacological targets and the substances that act on them. It contains information on over 1,800 drug targets and 1,100 related proteins. The database is curated by 500 experts and provides detailed pharmacological data as well as overviews of key properties and ligands. Specialized extensions of GtoPdb include guides to immunopharmacology and malaria pharmacology that connect their fields to drug discovery. The database is continuously updated with new targets, ligands, features and access methods.
Presentation by Dr. Elena Faccenda on the IUPHAR/BPS Guide to Immunopharmacology at the 39° Congresso Nazionale della Società Italiana di Farmacologia in Florence, Nov 2019
This document discusses the IUPHAR/BPS Guide to Pharmacology database and related resources. It provides open access information on pharmacological targets and the substances that act on them. It includes over 1,700 human drug targets, 9,700 ligands including 1,300 approved drugs. Related databases include the Guide to Immunopharmacology and Guide to Malaria Pharmacology. The databases are regularly updated and include links to other resources to enable interoperability.
Poster presented at the Elixir All-Hands Meeting in Lisbon, June 2019. Gives a broad summary of Guide to Pharmacology activities in the last year. Emphasising new tools and our extension into malaria pharmacology.
The document provides an overview and progress report on database activities from April 2018 - March 2019. Key points include:
- Publications in peer-reviewed journals on the database and new immunopharmacology guide.
- Engagement through conferences, social media, and interactions with users seeking to improve the database.
- Ongoing development of the database interface and content, including expansion to new therapeutic areas.
- Statistics on usage, file downloads, and web service calls that show increasing interaction over time.
The document summarizes recent updates to the IUPHAR/BPS Guide to PHARMACOLOGY database. It describes new features including expanded target coverage with over 1,700 drug targets and 1,100 related proteins. A new Pharmacology Search Tool allows users to upload protein lists and find associated ligands. The database also now connects immunopharmacology by associating targets with immune processes, cell types, and diseases. Additionally, the guide describes collaborations to include antimalarial compound data and develop an IUPHAR/MMV Guide to Malaria Pharmacology.
Poster on GtoImmuPdb presented at European Congress of Immunology (Amsterdam, Sep 2018). Overview of the main data types and features included in this extension to the IUPHAR/BPS Guide to PHARMACOLOGY
The IUPHAR/BPS Guide to PHARMACOLOGY (GtoPdb) is an open, expert-driven database that contains information on over 1,700 pharmacological targets and the substances that act on them. The database provides overviews and detailed information on targets that is manually curated from literature and reviewed by experts. It aims to cover human drug targets and potential future therapeutic targets. New features of the database include search tools to find targets and ligands, information on diseases associated with targets and ligands, organization of ligand families, and comparison of ligand activity across species. The database content is available to download in various formats and its interoperability has been increased through developing an RDF version and submitting data to other sources
The document provides an overview and status report of the Core Guide to PHARMACOLOGY (GtoPdb) database. It discusses recent publications from the team, compliance with new GDPR privacy regulations, website access statistics showing increased usage, new website features, and priorities for further development such as expanding disease and content coverage.
The document provides a status report on the Guide to Immunopharmacology database (GtoImmuPdb). It discusses developments including the addition of disease data, graphical browsing of cell type data, and process data. The database is in beta version 3 and undergoing user testing. Over 500 targets and 1,000 ligands have been curated from the literature. On the curation side, efforts are focused on expanding the literature collection and annotating new targets and ligands. The database is preparing for its official launch in October 2018.
The IUPHAR/BPS Guide to PHARAMCOLOGY in 2018: new features and updatesGuide to PHARMACOLOGY
2018 update poster for the IUPHAR/BPS Guide to PHARMACOLOGY. Giving details of new features and updates. To be presented at Pharmacology Futures, Edinburgh, May 2018; ELIXIR-All Hands, Berlin, June 2018 and World Congress of Pharmacology, Kyoto, Japan, July 2018
Updated poster following beta v3 release. In preparation for Pharmacology Futures, Edinburgh Immunology Symposium and Word Congress of Pharmacology (Kyoto)
IUPHAR/BPS Guide to PHARMACOLOGY in 2017: new features and updatesGuide to PHARMACOLOGY
This document summarizes updates to the IUPHAR/BPS Guide to PHARMACOLOGY database. It provides expert curated data on human drug targets and ligands. Recent additions include new target families, ligands, and links to immunopharmacology data. New features include download options, search tools, and organization of ligand families. The database is maintained by an international team and network of scientists and provides a resource for pharmacology education and research.
These slides will be presented at the Pharmacology 2017 meeting in London during the following session:
Abstract Number: OB073
Abstract Title: Capturing new BIA 10-2474 molecular data in the IUPHAR/BPS Guide to PHARMACOLOGY
Date: Wednesday, December 13, 2017, 11:30 AM
Oral Session: Oral Communications: Mixed Tracks
This comprehensive slide deck is provided for use by those who are teaching and presenting on the IUPHAR/BPS Guide to PHARMACOLOGY. Includes:
- Overview of NC-IUPHAR
- Background to GtoPdb
- Screenshots of the website and search tools
- Recent content expansions
- Other features and initiatives including the Guide to IMMUNOPHARMACOLOGY
This slide set updates the previous set from 2014/15 available at https://www.slideshare.net/GuidetoPHARM/iupharbps-guide-to-pharmacology-generic-slideset
Navigating links between structures and papers:
PubMed-to-PubChem connectivity between the IUPHAR/BPS Guide to PHARMACOLOGY and British Journal of Pharmacology
A poster presented at Pharmacology 2017, London, December 2017
Types of Garden (Mughal and Buddhist style)saloniswain225
Garden is the place where, flower blooming on a plant ,aesthetic things are present like Topiary, Hedges, Arches and many more. Whereas, Botanical garden is an educational institution for scientific research as well as gathering information about different culture. Such as, Hindu, Mughal , Buddhist style.
Comparison of Water Bodies in Delhi and LakshadweepAnoop Singh Nagi
Comparison of Water Bodies in Delhi and Lakshadweep - Anoop Singh Nagi
Water bodies play a crucial role in shaping the ecology and
lifestyle of regions. This presentation compares the water
bodies in Delhi and Lakshadweep, providing insights into
their types, characteristics, and environmental challenges.
Delhi, a bustling metropolis, features primarily freshwater
bodies such as rivers, lakes, and canals that face significant
pollution issues. In contrast, Lakshadweep, an archipelago in
the Arabian Sea, boasts pristine marine ecosystems including
lagoons and coral reefs known for their rich biodiversity and
clear waters. Understanding these differences highlights the
unique environmental contexts and conservation needs of
each region.
Please Like our PPT for supporting.
ScieNCE grade 08 Lesson 1 and 2 NLC.pptxJoanaBanasen1
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it................
just download it..............
Complement Activation Pathways: Key Mechanisms in Immune Defensedeepsarao2001
The complement system is a key part of the immune response, made up of proteins that eliminate pathogens. It is activated through three main pathways:
Classical Pathway: Triggered by antibodies bound to antigens on a pathogen's surface.
Lectin Pathway: Initiated by mannose-binding lectin binding to sugars on pathogens.
Alternative Pathway: Activated spontaneously on pathogen surfaces without antibodies.
All pathways converge to form C3 convertase, leading to the destruction of pathogens by marking them for immune attack and creating pores in their membranes. This process enhances the body's ability to fight infections quickly and effectively.
Measuring gravitational attraction with a lattice atom interferometerSérgio Sacani
Despite being the dominant force of nature on large scales, gravity remains relatively
elusive to precision laboratory experiments. Atom interferometers are powerful tools
for investigating, for example, Earth’s gravity1
, the gravitational constant2
, deviations
from Newtonian gravity3–6
and general relativity7
. However, using atoms in free fall
limits measurement time to a few seconds8
, and much less when measuring
interactions with a small source mass2,5,6,9
. Recently, interferometers with atoms
suspended for 70 s in an optical-lattice mode fltered by an optical cavity have been
demonstrated10–14. However, the optical lattice must balance Earth’s gravity by
applying forces that are a billionfold stronger than the putative signals, so even tiny
imperfections may generate complex systematic efects. Thus, lattice interferometers
have yet to be used for precision tests of gravity. Here we optimize the gravitational
sensitivity of a lattice interferometer and use a system of signal inversions to suppress
and quantify systematic efects. We measure the attraction of a miniature source mass
to be amass = 33.3 ± 5.6stat ± 2.7syst nm s−2, consistent with Newtonian gravity, ruling out
‘screened ffth force’ theories3,15,16 over their natural parameter space. The overall
accuracy of 6.2 nm s−2 surpasses by more than a factor of four the best similar
measurements with atoms in free fall5,6
. Improved atom cooling and tilt-noise
suppression may further increase sensitivity for investigating forces at sub-millimetre
ranges17,18, compact gravimetry19–22, measuring the gravitational Aharonov–Bohm
efect9,23 and the gravitational constant2
, and testing whether the gravitational feld
has quantum properties24.
Science-9-Lesson-1 ang lesson 2-NLC-pptx.pptxJoanaBanasen1
just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it! just check it!
PART 1 The New Natural Principles of Electromagnetism and Electromagnetic Fie...Thane Heins
Document Summary and the History of Perpetual Motion
Every single Faraday Generator coil since 1834 has been and is currently performing Negative Work at infinite efficiency with created Electromagnetic Field Energy during electricity generation and its physical Kinetic Energy reduction or Electromagnetic Resistance of the changing magnetic field which is initially inducing Electric Current in the generator coil according to Faraday's Law of Induction.
The Work-Energy Principle confirms mathematically that the magnitude of the changing magnetic field's Kinetic Energy reduction is equal to the magnitude of Negative Work performed at infinite efficiency, which is equal to the magnitude of Energy (Electromagnetic Field Energy which is created according to Oersted's Law of Creation of Energy of 1820). Created Electromagnetic Field Energy is required in order to perform the Negative Work – because Work cannot be performed in the absence of Energy.
In 2007 Thane Heins of Almonte Ontario, Canada discovered that unlimited amounts of Positive Electromechanical Work could be performed at infinite efficiency with created and TIME DELAYED Electromagnetic Field Energy.
Every single ReGenX Generator coil since 2007 has been and is currently performing Positive Work at infinite efficiency with created Electromagnetic Field Energy during electricity generation and during its physical Kinetic Energy increase or Electromagnetic Assistance of the changing magnetic field which is initially inducing Electric Current in the generator coil according to Heins' Law of Induction.
Faraday Electric Generators all harness internally Created Electromagnetic Field Energy in order to perform Negative Work (system Kinetic Energy reduction) at infinite efficiency and ReGenX Electric Generators harness internally created and Time Delayed Electromagnetic Field Energy in order to perform Positive Work (system Kinetic Energy increase) at infinite efficiency.
Both Faraday Generators and ReGenX Generators operate as Perpetual Motion Machines of the First Kind because they both have the ability to perform both Negative or Positive Work indefinitely and at infinite efficiency without requiring any External Energy input. The unlimited Energy required to perform either the Negative or Positive Work is created at the Sub-Atomic Quantum Electron level inside the generators' Current Bearing Wires according to the Law of Creation of Energy.
Hans Christian Oersted discovered the Law of Creation of Energy in 1820 when he demonstrated the world's first Perpetual Motion Machine of the First Kind at the University of Copenhagen when he also simultaneously violated Newton's 1st, 2nd and 3rd Laws of Motion.
Michael Faraday built and demonstrated the world's second Perpetual Motion Machine of the First Kind in 1822 when he demonstrated his Electric Motor invention which harnessed created Electromagnetic Field Energy in order to perform Positive Electromechanical Work at infinite efficienc
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
just download it to see!
Centrifugation is a technique, based upon the behaviour of particles in an applied centrifugal filed.
Centrifugation is a mechanical process which involves the use of the centrifugal force to separate particles from a solution according to their size, shape, density, medium viscosity and rotor speed.
The denser components of the mixture migrate away from the axis of the centrifuge, while the less dense components of the mixture migrate towards the axis.
precipitate (pellet) will travel quickly and fully to the bottom of the tube.
The remaining liquid that lies above the precipitate is called a supernatant.
ppt on Introduction to Nursing Research 2.pptarunjms86
Introduction to Nursing Research
Nursing research is an essential component of the nursing profession, aimed at generating new knowledge and improving patient care through scientific inquiry. It involves systematic investigation, analysis, and application of findings to enhance healthcare practices and outcomes. This introduction provides an overview of the key concepts, methodologies, and significance of nursing research.
What is Nursing Research?
Nursing research is the systematic study of phenomena related to the practice of nursing. It seeks to develop knowledge that can be used to improve patient care, enhance the practice environment, and contribute to the health and well-being of individuals and communities. Nursing research encompasses a broad range of topics, including clinical practice, healthcare systems, education, and policy.
IMPORTANCES OF MICROBIAL TOXINS IN PLANT DISEASES.pptxsubrata raha
In living plant cells several interdependent biochemical reactions are taking place concurrently or in a well defined succession to sustain life. Disturbance of any of these metabolic reactions causes disruption of the physiological processes leading to the development of disease. The harmful substances produced by the pathogenic microorganisms which are responsible for such disturbances are called toxins. Toxins are effective in very low concentrations. Some are unstable or react quickly and are bound tightly to specific sites within the plant cell.
Some toxins act as general protoplasmic poisons and affect many species of plant of different families termed as non specific toxins, other are toxic to only a few plant species or varieties and are harmless to others. Many toxins exists in multiple forms that have different potency.
IMPORTANCES OF MICROBIAL TOXINS IN PLANT DISEASES.pptx
GtoImmPdb_flash_poster_presentation
1. Dr. Simon D. Harding, University of Edinburgh
Poster
PB134
● Improving data exchange between pharmacology and immunology
● Unique portal to immunological
data in the GtoPdb
● New ways to search, browse and
visualise immunological data ● Public, beta-release, Spring 2017
● Wellcome Trust-funded extension to
the existing GtoPdb
● Richly annotated data on immunological processes,
cell types and diseases
● Curated by expert sub-committees at
NC-IUPHAR
Processes
Targets Ligands
Cell types
Disease